Citations
[1] — Nedeltcheva AV, Scheer FA. (2014, August 21). Metabolic effects of sleep disruption, links to obesity and diabetes. [Link]
[2] — Roberts CJ, Campbell IC, Troop N. (2014, January 22). Increases in weight during chronic stress are partially associated with a switch in food choice towards increased carbohydrate and saturated fat intake. [Link]
[3] — Samson SL, Garber AJ. (2014, March). Metabolic syndrome. [Link]
[4] — Mumme K, Stonehouse W. (2015, February). Effects of medium-chain triglycerides on weight loss and body composition: a meta-analysis of randomized controlled trials. [Link]
[5] — St-Onge MP, Bosarge A. (2008, March). Weight-loss diet that includes consumption of medium-chain triacylglycerol oil leads to a greater rate of weight and fat mass loss than does olive oil. [Link]
[6] — Blake R, Trounce IA. (2014, April). Mitochondrial dysfunction and complications associated with diabetes. [Link]
[7] — Boudina S, Graham TE. (2014, September). Mitochondrial function/dysfunction in white adipose tissue. [Link]
[8] — Victor VM, Apostolova N, Herance R, Hernandez-Mijares A, Rocha M. (2009). Oxidative stress and mitochondrial dysfunction in atherosclerosis: mitochondria-targeted antioxidants as potential therapy. [Link]
[9] — Currais A. (2015, May). Ageing and inflammation - A central role for mitochondria in brain health and disease. [Link]
[10] — Breitenbach M, Rinnerthaler M, Hartl J, Stincone A, Vowinckel J, Breitenbach-Koller H, Ralser M. (2014, February). Mitochondria in ageing: there is metabolism beyond the ROS. [Link]
[11] — Gruber J, Fong S, Chen CB, Yoong S, Pastorin G, Schaffer S, Cheah I, Halliwell B. (2013, September-October 31). Mitochondria-targeted antioxidants and metabolic modulators as pharmacological interventions to slow ageing. [Link]
[12] — Schönfeld P, Wojtczak L. (2016, June). Short- and medium-chain fatty acids in energy metabolism: the cellular perspective. [Link]
[13] — Rössle C, Carpentier YA, Richelle M, Dahlan W, D'Attellis NP, Fürst P, Elwyn DH. (1990, June). Medium-chain triglycerides induce alterations in carnitine metabolism. [Link]
[14] — Ferramosca A, Conte A, Damiano F, Siculella L, Zara V. (2014, June). Differential effects of high-carbohydrate and high-fat diets on hepatic lipogenesis in rats. [Link]
[15],[20] — Crescenzo R, Bianco F, Coppola P, Mazzoli A, Cigliano L, Liverini G, Iossa S. (2015, March). The effect of high-fat -high-fructose diet on skeletal muscle mitochondrial energetics in adult rats. [Link]
[16] — De Souza MC, Deschênes ME, Laurencelle S, Godet P, Roy CC, Djilali-Saiah I. (2016). Pure Oats as Part of the Canadian Gluten-Free Diet in Celiac Disease: The Need to Revisit the Issue. [Link]
[17] — Coelho LC, Silva PM, Lima VL, Pontual EV, Paiva PM, Napoleão TH, Correia MT. (2017). Lectins, Interconnecting Proteins with Biotechnological/Pharmacological and Therapeutic Applications. [Link]
[18] — Varki A, Cummings RD, Esko JD, et al., editors. Essentials of Glycobiology. 2nd edition. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 2009.[Link]
[19],[23] — Cordain L, Toohey L, Smith MJ, Hickey MS. (2000, March). Modulation of immune function by dietary lectins in rheumatoid arthritis. [Link]
[21] — Lavelle EC, Grant G, Pusztai A, Pfüller U, O'Hagan DT. (2001, January). The identification of plant lectins with mucosal adjuvant activity. [Link]
[22] — Bajaj M, Hinge A, Limaye LS, Gupta RK, Surolia A, Kale VP. (2011, April). Mannose-binding dietary lectins induce adipogenic differentiation of the marrow-derived mesenchymal cells via an active insulin-like signaling mechanism. [Link]
[24] — Sjölander A, Magnusson KE, Latkovic S. (1984). The effect of concanavalin A and wheat germ agglutinin on the ultrastructure and permeability of rat intestine. A possible model for an intestinal allergic reaction. [Link]
[25] — Vasconcelos IM, Oliveira JT. (2004, September). Antinutritional properties of plant lectins. [Link]
[26] — Stutz K, Kaech A, Aebi M, Künzler M, Hengartner MO. (2015, June). Disruption of the C. elegans Intestinal Brush Border by the Fungal Lectin CCL2 Phenocopies Dietary Lectin Toxicity in Mammals. [Link]
[27] — Cherqui G, Caron M, Capeau J, Picard J. (1983, July). Evidence for surface glycoprotein involvement in the intracellular bioactivity of insulin in rat adipocytes. [Link]
[28] — Macdonald IA. (2016, November). A review of recent evidence relating to sugars, insulin resistance and diabetes. [Link]
[29] — Lee BC, Lee J. (2014, March). Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance. [Link]
[30] — Brown AC, Valiere A. (2004, April-June). Probiotics and medical nutrition therapy. [Link]
[31] — Comeford K, Pasin G. (2017, July). Gene–Dairy Food Interactions and Health Outcomes: A Review of Nutrigenetic Studies. [Link]
[32] — Silanikove N, Leitner G, Merin U. (2015, August 31). The Interrelationships between Lactose Intolerance and the Modern Dairy Industry: Global Perspectives in Evolutional and Historical Backgrounds. [Link]
[33] — Temple JL, Cordero P, Li J, Nguyen V, Oben JA. (2016, June 15). A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence. [Link]
[34] — Mikolasevic I, Milic S, Turk Wensveen T, Grgic I, Jakopcic I, Stimac D, Wensveen F, Orlic L. (2016 November 21-22). Nonalcoholic fatty liver disease - A multisystem disease? [Link]
[35] — Lustig RH. (2013, March). Fructose: it's "alcohol without the buzz". [Link]
[36],[58] — Rial SA, Karelis AD, Bergeron KF, Mounier C. (2016, May 12). Gut Microbiota and Metabolic Health: The Potential Beneficial Effects of a Medium Chain Triglyceride Diet in Obese Individuals. [Link]
[37] — Coleman H, Quinn P, Clegg ME. (2016, June). Medium-chain triglycerides and conjugated linoleic acids in beverage form increase satiety and reduce food intake in humans. [Link]
[38] — Paoli A. (2014, February). Ketogenic Diet for Obesity: Friend or Foe? [Link]
[39] — Wang Y, Liu Z, Han Y, Xu J, Huang W, Li Z. (2018, February 8). Medium Chain Triglycerides enhances exercise endurance through the increased mitochondrial biogenesis and metabolism. [Link]
[40] — Maalouf M, Rho JM, Mattson MP. (2009, March). The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. [Link]
[41],[42] — Lima PA, Sampaio LP, Damasceno NR. (2014, December). Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy. [Link]
[43] — Maalouf M, Sullivan PG, Davis L, Kim DY, Rho JM. (2007, March 2). Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation. [Link]
[44] — Jarrett SG, Milder JB, Liang LP, Patel M. (2008, August). The ketogenic diet increases mitochondrial glutathione levels. [Link]
[45] — Newman J, Verin E. (2014, August). β-hydroxybutyrate: Much more than a metabolite. [Link]
[46] — Burning fat not so sweet. (2010, February). [Link]
[47] — Kuo LE, Czarnecka M, Kitlinska JB, Tilan JU, Kvetnanský R, Zukowska Z. (2008, December). Chronic stress, combined with a high-fat/high-sugar diet, shifts sympathetic signaling toward neuropeptide Y and leads to obesity and the metabolic syndrome. [Link]
[48] — Park S, Kim DS, Kang S, Daily JW 3rd. (2011, February). A ketogenic diet impairs energy and glucose homeostasis by the attenuation of hypothalamic leptin signaling and hepatic insulin signaling in a rat model of non-obese type 2 diabetes. [Link]
[49],[50],[51] — Allen BG, Bhatia SK, Anderson CM, Eichenberger-Gilmore JM, Sibenaller ZA, Mapuskar KA, Schoenfeld JD, Buatti JM, Spitz DR, Fath MA. (2014). Ketogenic diets as an adjuvant cancer therapy: History and potential mechanism. [Link]
[52] — Khoo HE, Prasad KN, Kong KW, Jiang Y, Ismail A. (2011, February 18). Carotenoids and their isomers: color pigments in fruits and vegetables. [Link]
[53],[56] — Dashti HM, Mathew TC, Hussein T, Asfar SK, Behbahani A, Khoursheed MA, Al-Sayer HM, Bo-Abbas YY, Al-Zaid NS. (2004). Long-term effects of a ketogenic diet in obese patients. [Link]
[54] — Eyres L, Eyres MF, Chisholm A, Brown RC. (2016, April). Coconut oil consumption and cardiovascular risk factors in humans. [Link]
[55] — Baba N, Bracco EF, Hashim SA. (1982, April). Enhanced thermogenesis and diminished deposition of fat in response to overfeeding with diet containing medium chain triglyceride. [Link]
[57] — Nonaka Y, Takagi T, Inai M, Nishimura S, Urashima S, Honda K, Aoyama T, Terada S. (2016, August 1). Lauric Acid Stimulates Ketone Body Production in the KT-5 Astrocyte Cell Line. [Link]
[59] — Compound Summary for CID 8058. (2004, September 16). [Link]
[60] — Lu XY. (2017, December). The leptin hypothesis of depression: a potential link between mood disorders and obesity? [Link]
All information and results stated on this website are for information purposes only. The information is not specific medical advice for any individual. The content website and product should not substitute medical advice from a health professional. If you have a health problem, speak to your doctor or a health professional immediately about your condition.
Representations regarding the efficacy and safety of Keto Belly Burn have not been evaluated by the Food and Drug Administration. The FDA only evaluates foods and drugs, not supplements like these products. These products are not intended to diagnose, prevent, treat, or cure any disease. Click here to find evidence of tests, analysis, research, or studies describing the benefits, performance or efficacy of some of the ingredients of Keto Belly Burn based on the expertise of relevant professionals. Individual results may vary depending on the case.
Raposo International Enterprises Inc.
Braemar Court, Deighton Road, St. Michael
BB14017, Barbados
888-517-1007
contact@naturalnutritionhacks.com
